Latest news with #Medkart
Fashion Value Chain
5 days ago
- Business
- Fashion Value Chain
Medkart Launches Women-First Franchise Drive to Empower Local Health Leaders
Across India, women have long been the backbone of community health – managing medicine, caregiving, and decision-making in families. Yet when it comes to formal entrepreneurship in the healthcare sector, their presence remains limited. According to government data, only 20% of Indian entrepreneurs are women, and fewer still operate in sectors like retail pharmacy where compliance, capital, and operational complexity often deter first-time business owners. Medkart is creating a platform where women lead with knowledge, empathy, and impact in retail healthcare This gender gap is especially visible in the pharmacy sector, despite the fact that women already form the majority of healthcare decision influencers in households. Most pharmacy store owners continue to be male, even though India produces over 150,000 pharmacy graduates annually, with many qualified women unable to transition into business due to lack of support or structure. In response, Medkart Pharmacy – one of India's fastest-growing pharmacy retail chains – has announced a women-first franchise campaign to empower aspiring female entrepreneurs to become local health leaders. The initiative is designed to offer women a low-risk, structured path to business ownership in the high-impact healthcare space. Founded in 2014, Medkart operates 100+ stores across Gujarat, Rajasthan, and Maharashtra, and has helped over 10 lakh families save â¹650 crore on essential medicines. The company's model promotes WHO-GMP certified generic drugs and operates on a transparent, education-first approach to retail pharmacy. Visit for More Details. One of the biggest frustrations for customers seeking affordable treatment is that they often cannot get their full prescription filled at one store – especially when they ask for generic alternatives. Medkart solves this by offering both branded and generic medicines under one roof, eliminating the need to visit multiple chemists or compromise on affordability. Customers save time, money, and get trusted options in a single visit. The Medkart franchise system requires an all-inclusive investment of Rs. 8-9 lakhs. It includes everything from store setup, inventory, and branding, to staff recruitment, licensing, training, and a proprietary AI-powered inventory management dashboard. This software provides real-time analytics on stock levels, expiry tracking, billing, and demand forecasts – allowing franchisees to run lean, efficient, compliant and technology-enabled businesses. 'Inventory losses are one of the biggest reasons why small pharmacies fail,' said Ankur Agarwal, Co-founder and CEO of Medkart. 'We built our franchise model to eliminate that fear entirely. Partners receive the stock they need, when they need it – and anything that doesn't move is taken back.' 'Our goal is to simplify healthcare retail,' added Parasharan Chari, Co-founder and COO. 'We're making it easier for individuals – even without pharma experience – to own and operate clean, transparent medicine stores that actually help their communities. Women, in particular, bring empathy, discipline, and trust – qualities that are invaluable in healthcare entrepreneurship – and we're proud to be creating a platform where they can thrive.' Under this new campaign, women franchisees will receive additional mentorship, priority onboarding, and access to Medkart's Franchisee Academy – a structured training program covering medicine knowledge, customer interaction, business compliance, and use of Medkart's tech platform. The brand reports that most franchise partners reach breakeven within 3-6 months, with ROI typically achieved within the first year and a half. As India moves toward greater inclusion in healthcare entrepreneurship, Medkart's women-first initiative is a step toward ensuring that more women take on leadership roles in the health sector – not just as caregivers, but as business builders and community anchors. For franchise inquiries, visit or email bd@
Fashion Value Chain
23-05-2025
- Health
- Fashion Value Chain
Medkart Introduces India's First Room-Temperature Stable Nicorandil Tablets, Enhancing Accessibility to Cardiac Care
In a country where cardiac care costs continue to burden millions, Medkart introduces a game-changing innovation: India's first room-temperature stable generic Nicorandil tablets-making heart medication more accessible, affordable, and logistically convenient. Medkart, a leading generic medicine platform in India, proudly announces the launch of the nations most in-demand Nicorandil tablets which remain stable at room temperature. This innovation eliminates the need for cold-chain storage, reducing logistical challenges and making the medication more accessible and affordable for patients across diverse regions. The product is now available at all Medkart outlets. Refrigeration Not Required-India's First Room-Temperature Nicorandil is here Addressing Storage Challenges in Cardiac Medications Nicorandil is widely prescribed for the treatment of chronic stable angina. Due to its sensitivity to temperature and humidity, its storage has traditionally required stringent cold-chain logistics. This requirement often poses significant challenges, especially in rural and semi-urban areas where maintaining cold-chain infrastructure is difficult. Enhancing Affordability and Accessibility Medkarts room-temperature stable Nicorandil tablets are manufactured under WHO-GMP-certified facilities, ensuring high-quality standards. By eliminating the need for refrigeration, the company significantly reduces distribution costs, allowing the medication to be priced up to 80% lower than its branded counterparts. 'Our room-stable Nicorandil is more than a product-it's an answer to India's cold chain problem in heart care,' said Ankur Agarwal, Co-founder of Medkart. 'Were proving that innovation doesnt have to be expensive-it has to be relevant.' Dr Ramesh Mehta, a senior cardiologist based in Ahmedabad, added, 'Ensuring that a cardiac drug like Nicorandil remains effective without refrigeration is a major step forward, particularly for patients in remote regions. We've long seen efficacy compromised due to storage issues. This advancement will save lives and improve treatment consistency.' Tackling the Cardiovascular Disease Burden Cardiovascular diseases (CVDs) are a leading cause of mortality in India. According to the Global Burden of Disease Study, heart disease is the leading cause of death among women in India, accounting for almost 18% of all female deaths. Medkart's launch addresses both cost and accessibility in one formulation. Product Availability Medkart's room-stable Nicorandil tablets are now available at over 35000+ pincodes and online at To illustrate the cost difference between branded and Medkarts generic versions of Nicorandil tablets, here's a comparative snapshot based on real-time Medkart data: Product Type Strength Branded Price Per Tab (Rs.) Medkart Price Per Tab (Rs.) Savings (Rs.) Savings (%) Nicorandil 10 MG Tablet 10 mg Rs. 26.95 Rs. 5.2 Rs. 21.75 80.72% Nicorandil 5 MG Tablet 5 mg Rs. 16.5 Rs. 3.1 Rs. 13.4 81.21% *Prices are based on current Medkart data. Actual savings may vary. About Medkart Founded in 2014, Medkart is committed to making affordable healthcare accessible to all-especially for chronic conditions like heart disease, diabetes, and hypertension where long-term medication is critical. With a growing network of over 100+ retail outlets across India and a seamless online platform, Medkart empowers people to compare medicine prices, access WHO-GMP-certified generics, and receive reliable guidance from trained pharmacists. Having served over 11 lakh families and facilitated savings of more than Rs. 600 crore to date, Medkart leverages a tech-first approach through tools like dosage comparison, molecule-based search, store locator, and in-app ordering. Grounded in transparency and trust, Medkart continues to redefine India's pharmaceutical ecosystem by making quality treatment affordable for all.
